Peter Wipf

33.6k total citations · 3 hit papers
616 papers, 26.7k citations indexed

About

Peter Wipf is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Peter Wipf has authored 616 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 318 papers in Molecular Biology, 302 papers in Organic Chemistry and 64 papers in Oncology. Recurrent topics in Peter Wipf's work include Chemical Synthesis and Analysis (91 papers), Synthetic Organic Chemistry Methods (78 papers) and Asymmetric Synthesis and Catalysis (64 papers). Peter Wipf is often cited by papers focused on Chemical Synthesis and Analysis (91 papers), Synthetic Organic Chemistry Methods (78 papers) and Asymmetric Synthesis and Catalysis (64 papers). Peter Wipf collaborates with scholars based in United States, China and Switzerland. Peter Wipf's co-authors include John S. Lazo, Chris P. Miller, Amir H. Faraji, David N. Beratan, Valerian E. Kagan, Srikanth Venkatraman, Paul C. Fritch, Seth Ribe, Maciej A. Walczak and Heinz Heimgartner and has published in prestigious journals such as Nature, Science and Chemical Reviews.

In The Last Decade

Peter Wipf

604 papers receiving 26.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles in cellular drug delivery

2009 655 citations Peter Wipf et al. Bioorganic & Medicinal Chemistry profile →
Targeting Mitochondria

2008 562 citations Peter Wipf et al. profile →
Synthetic Studies of Biologically Active Marine Cyclopeptides

1995 521 citations Peter Wipf profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Wipf United States	84	13.0k	12.4k	2.1k	1.7k	1.6k	616	26.7k
Herbert Waldmann Germany	95	18.6k 1.4×	23.3k 1.9×	4.9k 2.3×	2.7k 1.6×	1.5k 1.0×	840	38.6k
Fernando Alberício Spain	85	14.9k 1.1×	20.0k 1.6×	2.3k 1.1×	2.6k 1.5×	1.1k 0.7×	935	30.7k
Hartmuth C. Kolb United States	48	24.5k 1.9×	15.4k 1.2×	1.2k 0.6×	1.6k 0.9×	1.6k 1.0×	137	37.9k
Kim D. Janda United States	76	7.1k 0.5×	12.5k 1.0×	1.9k 0.9×	1.1k 0.7×	1.4k 0.9×	601	23.1k
William A. Denny New Zealand	76	8.4k 0.6×	12.4k 1.0×	827 0.4×	4.3k 2.5×	710 0.5×	600	21.1k
Alan P. Kozikowski United States	76	9.1k 0.7×	12.4k 1.0×	2.8k 1.3×	3.1k 1.8×	962 0.6×	567	23.3k
Ettore Novellino Italy	71	7.4k 0.6×	12.9k 1.0×	2.6k 1.2×	2.2k 1.3×	732 0.5×	820	27.5k
Robert B. Murphy United States	27	5.6k 0.4×	13.0k 1.0×	2.3k 1.1×	2.3k 1.3×	1.1k 0.7×	39	23.0k
David P. Fairlie Australia	87	4.8k 0.4×	13.9k 1.1×	1.4k 0.7×	3.8k 2.2×	751 0.5×	466	28.6k
Michael E. Jung United States	55	7.6k 0.6×	4.7k 0.4×	988 0.5×	933 0.5×	527 0.3×	377	13.6k

Countries citing papers authored by Peter Wipf

Since Specialization

Citations

This map shows the geographic impact of Peter Wipf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wipf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wipf more than expected).

Fields of papers citing papers by Peter Wipf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wipf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wipf. The network helps show where Peter Wipf may publish in the future.

Co-authorship network of co-authors of Peter Wipf

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wipf. A scholar is included among the top collaborators of Peter Wipf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wipf. Peter Wipf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teixeira, Rayane Brinck, et al.. (2025). Targeting Mitochondrial Reactive Oxygen Species: JP4-039’s Potential as a Cardiovascular Therapeutic. Journal of Clinical Medicine. 14(18). 6465–6465.

Adeghate, Jennifer, Michael W. Epperly, Kira L. Lathrop, et al.. (2024). JP4-039, a Mitochondria-Targeted Nitroxide, Mitigates the Effect of Apoptosis and Inflammatory Cell Migration in the Irradiated Mouse Retina. International Journal of Molecular Sciences. 25(12). 6515–6515. 3 indexed citations

Wipf, Peter, et al.. (2023). Biological studies of clavine alkaloids targeting CNS receptors. Frontiers in Psychiatry. 14. 1286941–1286941. 5 indexed citations

Sannino, Sara, et al.. (2023). Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress. Molecular Cancer Research. 21(7). 675–690. 7 indexed citations

Lazo, John S., et al.. (2023). Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase. Journal of Pharmacology and Experimental Therapeutics. 384(3). 429–438. 7 indexed citations

Bhatia, Tarun N., Patrick G. Needham, Xiaoming Hu, et al.. (2021). Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy. Neurotherapeutics. 18(4). 2541–2564. 6 indexed citations

Kovler, Mark L., Andres Salazar, William B. Fulton, et al.. (2021). Toll-like receptor 4–mediated enteric glia loss is critical for the development of necrotizing enterocolitis. Science Translational Medicine. 13(612). eabg3459–eabg3459. 63 indexed citations

Peyser, Brian D., Ann Hermone, Joseph M. Salamoun, et al.. (2019). Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy. Molecular Cancer Therapeutics. 18(10). 1765–1774. 5 indexed citations

Dong, Jun, Zeyu Wu, Dan Wang, et al.. (2018). Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells. Molecular Cancer Therapeutics. 18(1). 39–50. 31 indexed citations

10.

Banerjee, Soojay, Alberto Bartesaghi, Alan Merk, et al.. (2016). 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science. 351(6275). 871–875. 269 indexed citations

11.

Johnston, Paul A., Malabika Sen, Yun Hua, et al.. (2015). HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. Assay and Drug Development Technologies. 13(7). 356–376. 24 indexed citations

12.

Johnston, Paul A., Elizabeth R. Sharlow, Andreas Vogt, et al.. (2015). Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B. Bioorganic & Medicinal Chemistry. 23(12). 2810–2818. 36 indexed citations

13.

Wei, Ning, Edward Chu, Peter Wipf, & John C. Schmitz. (2014). Protein Kinase D as a Potential Chemotherapeutic Target for Colorectal Cancer. Molecular Cancer Therapeutics. 13(5). 1130–1141. 54 indexed citations

14.

Escobales, Nelson, Sehwan Jang, Rebecca Parodi‐Rullán, et al.. (2014). Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. Journal of Molecular and Cellular Cardiology. 77. 136–146. 76 indexed citations

15.

Blackmon, Nicole L., Tong Ying Shun, Sunita N. Shinde, et al.. (2010). Profiling the NIH Small Molecule Repository for Compounds That Generate H ₂ O ₂ by Redox Cycling in Reducing Environments. Assay and Drug Development Technologies. 8(2). 152–174. 91 indexed citations

16.

Johnston, Paul A., Caleb Foster, Tong Ying Shun, et al.. (2009). Cdc25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library. Assay and Drug Development Technologies. 7(3). 250–265. 33 indexed citations

17.

Balachandran, Raghavan, et al.. (2008). Tubulin‐Perturbing Naphthoquinone Spiroketals. Chemical Biology & Drug Design. 71(2). 117–124. 3 indexed citations

18.

Johnston, Paul A., Sunita N. Shinde, Caleb Foster, et al.. (2008). Development of a 384-Well Colorimetric Assay to Quantify Hydrogen Peroxide Generated by the Redox Cycling of Compounds in the Presence of Reducing Agents. Assay and Drug Development Technologies. 6(4). 505–518. 96 indexed citations

19.

Johnston, Paul A., Caleb Foster, Tong Ying Shun, et al.. (2007). Development and Implementation of a 384-Well Homogeneous Fluorescence Intensity High-Throughput Screening Assay to Identify Mitogen-Activated Protein Kinase Phosphatase-1 Dual-Specificity Protein Phosphatase Inhibitors. Assay and Drug Development Technologies. 5(3). 319–332. 33 indexed citations

20.

Wipf, Peter & Christopher Kendall. (2002). Novel Applications of Alkenyl Zirconocenes. Chemistry - A European Journal. 8(8). 1778–1778. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact